Dyadic International, Inc.

Dyadic International, Inc.verified

DYAI

Price:

$1.74

Market Cap:

$51.49M

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validat...[Read more]

Industry

Biotechnology

IPO Date

2008-01-16

Stock Exchange

NASDAQ

Ticker

DYAI

The Current Ratio as of December 2024 (TTM) for Dyadic International, Inc. (DYAI) is 5.15

According to Dyadic International, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.15. This represents a change of 4.69% compared to the average of 4.92 of the last 4 quarters.

Dyadic International, Inc. (DYAI) Historical Current Ratio (quarterly & annually)

How has DYAI Current Ratio performed in the past?

The mean historical Current Ratio of Dyadic International, Inc. over the last ten years is 25.68. The current 5.15 Current Ratio has changed 1.90% with respect to the historical average. Over the past ten years (40 quarters), DYAI's Current Ratio was at its highest in in the June 2018 quarter at 97.72. The Current Ratio was at its lowest in in the June 2015 quarter at 0.73.

Quarterly (TTM)
Annual

Average

25.68

Median

20.38

Minimum

2.83

Maximum

64.53

Dyadic International, Inc. (DYAI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Dyadic International, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 750.65%

Maximum Annual Current Ratio = 64.53

Minimum Annual Increase = -55.39%

Minimum Annual Current Ratio = 2.83

Quarterly (TTM)
Annual
YearCurrent RatioChange
20233.58-34.64%
20225.48-33.32%
20218.22-55.12%
202018.32-18.38%
201922.44-55.39%
201850.31-22.03%
201764.5313.12%
201657.04136.92%
201524.08750.65%
20142.83-15.63%

Dyadic International, Inc. (DYAI) Average Current Ratio

How has DYAI Current Ratio performed in the past?

The current Current Ratio of Dyadic International, Inc. (DYAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.76

5-year avg

11.61

10-year avg

25.68

Dyadic International, Inc. (DYAI) Current Ratio vs. Peers

How is DYAI’s Current Ratio compared to its peers?

Dyadic International, Inc.’s Current Ratio is less than Werewolf Therapeutics, Inc. (10.10), less than Edgewise Therapeutics, Inc. (26.35), greater than Decibel Therapeutics, Inc. (4.81), less than Celcuity Inc. (10.36), less than C4 Therapeutics, Inc. (6.31), greater than Anebulo Pharmaceuticals, Inc. (3.45), less than PMV Pharmaceuticals, Inc. (13.98), less than AN2 Therapeutics, Inc. (9.75), less than Eliem Therapeutics, Inc. (0), greater than HCW Biologics Inc. (0.07), less than Molecular Partners AG (14.33), less than MediciNova, Inc. (16.66), greater than Champions Oncology, Inc. (0.75), less than Cyteir Therapeutics, Inc. (21.89), greater than Forte Biosciences, Inc. (2.06), less than DiaMedica Therapeutics Inc. (11.81), greater than Kineta, Inc. (0.14), greater than Kintara Therapeutics, Inc. (2.45),

Build a custom stock screener for Dyadic International, Inc. (DYAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dyadic International, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dyadic International, Inc. (DYAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dyadic International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Dyadic International, Inc.'s Current Ratio?

How is the Current Ratio calculated for Dyadic International, Inc. (DYAI)?

What is the highest Current Ratio for Dyadic International, Inc. (DYAI)?

What is the 3-year average Current Ratio for Dyadic International, Inc. (DYAI)?

What is the 5-year average Current Ratio for Dyadic International, Inc. (DYAI)?

How does the current Current Ratio for Dyadic International, Inc. (DYAI) compare to its historical average?